Eiko Lifesciences Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Revenue growth of 15% in the latest quarter indicates strong market demand.
Margins improved by 5%, showcasing better cost management strategies.
Investment in R&D shows commitment to innovation, positioning for future growth.

NEGATIVES

Field	Mar 20	Jun 20	Sep 20	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25	Sep 25
Revenue	0.62	0.56	0.84	10.75	8.15	7.49	11.27	10.71	11.67
Expenses	1.54	0.42	0.89	10.36	7.73	6.85	9.96	9.20	9.91
Operating Profit	-0.92	0.14	-0.05	0.39	0.42	0.63	1.31	1.51	1.76
Other Income	-0.04	0.05	0.01	0.26	0.13	0.09	0.23	0.27	0.26
Interest	0.03	0.01	0.10	0.03	0.04	0.03	0.07	0.05	0.10
Depreciation	0.05	0.04	0.04	0.16	0.16	0.16	0.25	0.25	0.26
Profit Before Tax	-1.03	0.14	-0.17	0.49	0.38	0.57	1.64	1.49	1.71
Tax	-0.29	0.03	-0.04	0.11	0.09	0.14	0.39	0.37	0.43
Net Profit	-0.74	0.10	-0.13	0.37	0.28	0.42	1.24	1.12	1.28
Eps in Rs	-1.08	0.17	-0.14	0.29	0.22	0.32	0.80	0.66	0.78